Mary Thompson

Executive Editor, MedTech Strategist

25 Years of Experience

About

A founding member of the MedTech Strategist editorial team, @MaryThompsonMTS has 25+ years of experience covering technologies and trends in the medical device industry. She currently focuses on the cardiovascular, diabetes, and digital health markets. Prior to joining MedTech Strategist, Mary was Managing Editor/Executive Editor of the Medtech Insight Newsletter, a position she held for nearly 14 years, and she was instrumental in the initial conceptualization and launch of that publication. Mary’s extensive editorial experience combined with her early background as an R&D scientist brings a unique balance of expertise and perspective to her work.

Specialties
Publications
Articles from Mary Thompson:
Read all from this author
Business Strategies

Eli Lilly Bets on Diabetes Cell Therapy With Sigilon Buy

  • 2023-12-04 00:00:00.0
  • Mary Thompson
  • Community Blog

Device companies are not the only ones broadening their diabetes portfolio. Lilly is one of several companies working to develop implantable beta cell therapies, which researchers hope may one day be able to cure type 1 diabetes. Excerpted from our recent feature article.

Read Article